Press news Biocartis Group NV: Biocartis Announces Partnership with Endpoint Health to Develop Novel Companion Diagnostic in Critical Illness

NEXT STORY
Everest Medicines Announces First Patient Dosed in its Phase 2b Registration Clinical Trial of Trodelvy™ (sacituzumab govitecan) for Metastatic Triple-Negative Breast Cancer in China
PREV STORY
Valneva Reports Nine Month Results Marked by Further Major Corporate Achievements
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Benasource Selects Acupath Laboratories to Bring COVID-19 Saliva PCR Assay to Independent Pharmacies Across the Country

author_avatar
NASDAQ Market News

Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update

The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3The ...

author_avatar
NASDAQ Market News

Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at the IASLC 2021 World Conference on Lung Cancer

author_avatar
NASDAQ Market News